Max Dawson
Directeur des opérations chez DermBiont, Inc.
Profil
Max N.
Dawson is currently the Chief Operating Officer at DermBiont, Inc. He previously worked as the Head-Program Finance at Vertex Pharmaceuticals, Inc., an Analyst-Finance & Operations at Merck KGaA, the Head-Business Development at Dyax Corp., and the Vice President-Business Development at Adagene, Inc. He holds an MBA from Babson College and an undergraduate degree from Bates College.
Postes actifs de Max Dawson
| Sociétés | Poste | Début |
|---|---|---|
DermBiont, Inc.
 DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | Directeur des opérations | 01/09/2019 |
Anciens postes connus de Max Dawson
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | - |
| DYAX CORP. | Corporate Officer/Principal | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
| ADAGENE INC. | Corporate Officer/Principal | - |
Formation de Max Dawson
| Babson College | Masters Business Admin |
| Bates College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ADAGENE INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| MERCK KGAA | Health Technology |
| Entreprise privées | 2 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
DermBiont, Inc.
DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | Commercial Services |
